Developer docs
API playgroundTry for free, no card

Search company profiles

Inspiralis

Full company profile

uuid0032nne

Namestring
Inspiralis
Websiteurl
inspiralis.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Inspiralis is a privately held life sciences company headquartered in Norwich, United Kingdom, founded in 1995. According to its stated positioning, the company supplies high-quality topoisomerase research products to two end-markets: the pharmaceutical industry and academic research institutions. Topoisomerases are enzymes that regulate DNA supercoiling and are significant targets in drug discovery, particularly for oncology and antibacterial therapeutics, placing the firm in a narrow specialty within the research-reagents and enzyme-tools market. The company remains private with no recorded funding rounds, parent organization, or public-market signals, indicating it has historically operated as an independent, founder-led specialty supplier.

Operationally, Inspiralis is a micro-entity with a reported headcount of 1-10 employees, consistent with a boutique reagent supplier rather than a scaled distributor or platform. Granular details on the product catalog (specific assay kits, enzymes, or screening platforms), proprietary technology, pricing structure, distribution model, and revenue mechanics are not available in the input data. The company's website (inspiralis.com) currently displays only a verification loading page rather than substantive content, and no management team, contact directory, certifications, partnerships, awards, or financial disclosures have been recorded. As a result, the verifiable scope of the business is limited to its name, location, founding year, headcount band, and the high-level description of its topoisomerase product line serving pharma and academia.

From an investment-intelligence standpoint, the available evidence supports classifying Inspiralis as a small, long-tenured specialty reagent business in a defensible biochemistry niche, but the absence of product, financial, leadership, and traction data means that any deeper assessment of growth, moat depth, or strategic direction cannot be supported beyond what is stated here.

Short descriptiontext

Inspiralis is a Norwich, UK-based private life sciences company, founded in 1995, that supplies topoisomerase research products to the pharmaceutical industry and academic researchers.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNorwich, United Kingdom
HQ citystring
Norwich
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
topoisomerase research products, DNA topoisomerase assays, molecular biology reagents, enzyme research products, pharmaceutical research tools
Industry1 code
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Molecular Biology Reagents
Social media profiles1 record
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Inspiralis supplies high-quality topoisomerase research products to the pharmaceutical industry and to academic research institutions. Its offerings are biological reagents used in molecular biology and biochemistry research focused on DNA topoisomerase enzymes and their applications in drug discovery and basic science.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Topoisomerase Research Products
CategoryMolecular Biology Reagents
Description

Biological research reagents related to DNA topoisomerase enzymes, supplied for use by pharmaceutical R&D laboratories and academic research groups studying DNA topology, enzyme mechanisms, and inhibitor screening.

No data
Peers8 records
TypeDirect peer
Description

Cayman supplies biochemicals and assay reagents for research, including tools relevant to topoisomerase inhibitor screening and mechanism-of-action studies, addressing the same pharma and academic customers.

TypeBroad incumbent
Description

Through brands such as Invitrogen and Thermo Scientific, Thermo Fisher offers topoisomerase enzymes and DNA-modifying reagents alongside a comprehensive life-sciences portfolio, often serving as the default supplier to large pharma and academic cores.

TypeDirect peer
Description

Enzo Life Sciences offers enzyme assays, inhibitor screening kits, and DNA-related research reagents, with overlapping use cases for researchers studying topoisomerases and DNA replication.

TypeDirect peer
Description

TopoGEN, now part of Cytodiagnostics, historically supplied topoisomerase assay kits, antibodies, and enzymes for research — overlapping directly with Inspiralis's topoisomerase reagent catalog and serving the same academic and pharma screening customers.

TypeEmerging player
Description

Active Motif specializes in chromatin, DNA-modifying enzymes, and epigenetics research reagents, providing products that intersect with topoisomerase research in DNA topology and chromatin biology applications.

TypeBroad incumbent
Description

Promega manufactures a broad range of enzymes, assay systems, and drug-discovery reagents that overlap with Inspiralis's customer base in molecular biology and drug-target research laboratories.

TypeBroad incumbent
Description

MilliporeSigma distributes a vast catalog of enzymes, biochemicals, and assay kits including topoisomerase-related products, supplying the same pharma and academic customers with the convenience of consolidated procurement.

TypeBroad incumbent
Description

NEB is a major specialty enzyme manufacturer offering topoisomerases and related DNA-modifying enzymes used in molecular biology research. It competes for the same reagent budget at academic and pharma labs, albeit as a much broader catalog supplier.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Inspiralis

Molecular Biology Reagentsinspiralis.com

Inspiralis is a Norwich, UK-based private life sciences company, founded in 1995, that supplies topoisomerase research products to the pharmaceutical industry and academic researchers.

What Inspiralis does

Inspiralis is a privately held life sciences company headquartered in Norwich, United Kingdom, founded in 1995. According to its stated positioning, the company supplies high-quality topoisomerase research products to two end-markets: the pharmaceutical industry and academic research institutions. Topoisomerases are enzymes that regulate DNA supercoiling and are significant targets in drug discovery, particularly for oncology and antibacterial therapeutics, placing the firm in a narrow specialty within the research-reagents and enzyme-tools market. The company remains private with no recorded funding rounds, parent organization, or public-market signals, indicating it has historically operated as an independent, founder-led specialty supplier.

Operationally, Inspiralis is a micro-entity with a reported headcount of 1-10 employees, consistent with a boutique reagent supplier rather than a scaled distributor or platform. Granular details on the product catalog (specific assay kits, enzymes, or screening platforms), proprietary technology, pricing structure, distribution model, and revenue mechanics are not available in the input data. The company's website (inspiralis.com) currently displays only a verification loading page rather than substantive content, and no management team, contact directory, certifications, partnerships, awards, or financial disclosures have been recorded. As a result, the verifiable scope of the business is limited to its name, location, founding year, headcount band, and the high-level description of its topoisomerase product line serving pharma and academia.

From an investment-intelligence standpoint, the available evidence supports classifying Inspiralis as a small, long-tenured specialty reagent business in a defensible biochemistry niche, but the absence of product, financial, leadership, and traction data means that any deeper assessment of growth, moat depth, or strategic direction cannot be supported beyond what is stated here.

Inspiralis firmographics

Firmographics
Name
Inspiralis
Website
https://inspiralis.com
Company type
Private
Founded year
2006
Headcount range
11–50 employees
Short description
Inspiralis is a Norwich, UK-based private life sciences company, founded in 1995, that supplies topoisomerase research products to the pharmaceutical industry and academic researchers.
Ownership category
akta.pro rank

Inspiralis industry classification

Industry
Product category
Molecular Biology Reagents
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)

Keywords

  • Topoisomerase research products
  • DNA topoisomerase assays
  • Molecular biology reagents
  • Enzyme research products
  • Pharmaceutical research tools

Where Inspiralis is headquartered

Location

Headquarters

HQ city
Norwich
HQ country
United Kingdom
HQ region
Europe

Markets served

Inspiralis business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing

Inspiralis product offering

Product offering

Core offering

Inspiralis supplies high-quality topoisomerase research products to the pharmaceutical industry and to academic research institutions. Its offerings are biological reagents used in molecular biology and biochemistry research focused on DNA topoisomerase enzymes and their applications in drug discovery and basic science.

Differentiator

Problem solved

Functional benefit

Products and services

  • Topoisomerase Research Products Biological research reagents related to DNA topoisomerase enzymes, supplied for use by pharmaceutical R&D laboratories and academic research groups studying DNA topology, enzyme mechanisms, and inhibitor screening.

Companies that use Inspiralis

Customer profile

Ideal customer profiles2 records

Inspiralis technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Inspiralis competitors and assessment

Company assessment

Direct peers

  • Cayman Chemical: Cayman supplies biochemicals and assay reagents for research, including tools relevant to topoisomerase inhibitor screening and mechanism-of-action studies, addressing the same pharma and academic customers.
  • Enzo Life Sciences: Enzo Life Sciences offers enzyme assays, inhibitor screening kits, and DNA-related research reagents, with overlapping use cases for researchers studying topoisomerases and DNA replication.
  • TopoGEN (Cytodiagnostics): TopoGEN, now part of Cytodiagnostics, historically supplied topoisomerase assay kits, antibodies, and enzymes for research — overlapping directly with Inspiralis's topoisomerase reagent catalog and serving the same academic and pharma screening customers.

Broad incumbents

  • Thermo Fisher Scientific: Through brands such as Invitrogen and Thermo Scientific, Thermo Fisher offers topoisomerase enzymes and DNA-modifying reagents alongside a comprehensive life-sciences portfolio, often serving as the default supplier to large pharma and academic cores.
  • Promega Corporation: Promega manufactures a broad range of enzymes, assay systems, and drug-discovery reagents that overlap with Inspiralis's customer base in molecular biology and drug-target research laboratories.
  • Sigma-Aldrich (MilliporeSigma): MilliporeSigma distributes a vast catalog of enzymes, biochemicals, and assay kits including topoisomerase-related products, supplying the same pharma and academic customers with the convenience of consolidated procurement.
  • New England Biolabs: NEB is a major specialty enzyme manufacturer offering topoisomerases and related DNA-modifying enzymes used in molecular biology research. It competes for the same reagent budget at academic and pharma labs, albeit as a much broader catalog supplier.

Emerging players

  • Active Motif: Active Motif specializes in chromatin, DNA-modifying enzymes, and epigenetics research reagents, providing products that intersect with topoisomerase research in DNA topology and chromatin biology applications.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

Inspiralis social profiles

Digital presence

Inspiralis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Inspiralis leadership team

Management profile

Number of profiles

Inspiralis funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Inspiralis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inspiralis

What does Inspiralis do?

Inspiralis supplies high-quality topoisomerase research products to the pharmaceutical industry and to academic research institutions. Its offerings are biological reagents used in molecular biology and biochemistry research focused on DNA topoisomerase enzymes and their applications in drug discovery and basic science.

When was Inspiralis founded?

Inspiralis was founded in 2006. It employs 11 to 50 people.

Where is Inspiralis based?

Inspiralis is headquartered in Norwich, United Kingdom, in the Europe region.

Who are Inspiralis's main competitors?

Direct peers on record are Cayman Chemical, Enzo Life Sciences and TopoGEN (Cytodiagnostics). Broad incumbents are Thermo Fisher Scientific, Promega Corporation, Sigma-Aldrich (MilliporeSigma) and New England Biolabs. Active Motif is listed as an emerging player.

Does Inspiralis have an API?

No public API is recorded for Inspiralis.

What industry is Inspiralis in?

Inspiralis's product category is Molecular Biology Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales